Antares Pharma Inc $3.96
|Trade Time:||Dec 13 02:08 PM Eastern Daylight Time|
|Change:||-0.02 (-0.38 %)|
Quotes displayed are delayed by 15 minutes. Market data is provided by Xignite
Get ATRS Trend Analysis - it has underperformed the S&P 500 by 21%
|No ETF alternatives available.|
|Date||Name||Title||Volume||Trade Price||Holding Change|
|12/09/2013||Wotton Paul K||President and CEO||-18,100||$4.00||-2.49%|
|12/09/2013||Wotton Paul K||President and CEO||18,100||$0.50||2.55%|
|12/06/2013||Wotton Paul K||President and CEO||46,000||$0.50||6.49%|
|12/06/2013||Wotton Paul K||President and CEO||-46,000||$4.00||-6.09%|
|10/14/2013||APPLE ROBERT F||Executive Vice President & CFO||-22,000||$5.06||-5.63%|
ATRS Stock Analysis
- No results found.
Get the four benefits of managed futures as outlined in this booklet.
Learn from Warren Buffett, George Soros and More!
Discover Investing Strategies that will Benefit Every Investor Today!